- Home
- WSR vs ARCT Comparison
WSR vs ARCT Comparison
Compare WSR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSR
- ARCT
- Stock Information
- Founded
- WSR 1998
- ARCT 2013
- Country
- WSR United States
- ARCT United States
- Employees
- WSR N/A
- ARCT N/A
- Industry
- WSR Real Estate Investment Trusts
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- WSR Real Estate
- ARCT Health Care
- Exchange
- WSR Nasdaq
- ARCT Nasdaq
- Market Cap
- WSR 729.8M
- ARCT 602.7M
- IPO Year
- WSR 2010
- ARCT N/A
- Fundamental
- Price
- WSR $15.26
- ARCT $15.24
- Analyst Decision
- WSR Strong Buy
- ARCT Strong Buy
- Analyst Count
- WSR 3
- ARCT 7
- Target Price
- WSR $15.67
- ARCT $65.00
- AVG Volume (30 Days)
- WSR 221.5K
- ARCT 380.6K
- Earning Date
- WSR 10-30-2024
- ARCT 11-07-2024
- Dividend Yield
- WSR 3.27%
- ARCT N/A
- EPS Growth
- WSR N/A
- ARCT N/A
- EPS
- WSR 0.41
- ARCT N/A
- Revenue
- WSR $149,446,000.00
- ARCT $160,399,000.00
- Revenue This Year
- WSR N/A
- ARCT $6.91
- Revenue Next Year
- WSR $4.35
- ARCT $5.24
- P/E Ratio
- WSR $37.08
- ARCT N/A
- Revenue Growth
- WSR 4.67
- ARCT N/A
- 52 Week Low
- WSR $10.77
- ARCT $14.93
- 52 Week High
- WSR $15.26
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- WSR 69.63
- ARCT 37.77
- Support Level
- WSR $14.33
- ARCT $15.55
- Resistance Level
- WSR $14.57
- ARCT $20.92
- Average True Range (ATR)
- WSR 0.25
- ARCT 1.11
- MACD
- WSR 0.07
- ARCT -0.17
- Stochastic Oscillator
- WSR 98.28
- ARCT 4.56
About WSR Whitestone REIT
Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. Its property portfolio includes retail and office/flex properties. The company's properties are located in business-friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The organization derives revenue in the form of rental revenues.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.